Segment Information - Financial Information by Segment (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2024 USD ($) segment	Mar. 31, 2023 USD ($)
Segment Reporting, Revenue Reconciling Item [Line Items]
Net revenue	$ 2,612,680	$ 2,522,849
Operating income	9,696	9,807
Acquisition-related charges and intangible amortization	20,313	22,188
Exit and realignment charges, net	(27,356)	(15,674)
Depreciation and amortization	74,095	70,926
Share-based compensation	6,866	6,463
Capital expenditures	$ 49,408	51,490
Number of Reportable Segments | segment	2
Operating Segments
Segment Reporting, Revenue Reconciling Item [Line Items]
Net revenue	$ 2,612,680	2,522,849
Operating Segments | Products & Healthcare Services
Segment Reporting, Revenue Reconciling Item [Line Items]
Net revenue	1,974,837	1,915,489
Operating income	11,486	1,820
Depreciation and amortization	23,366	18,566
Share-based compensation	4,769	4,498
Capital expenditures	8,250	6,332
Operating Segments | Patient Direct
Segment Reporting, Revenue Reconciling Item [Line Items]
Net revenue	637,843	607,360
Operating income	45,879	45,849
Depreciation and amortization	50,729	52,360
Share-based compensation	1,407	1,852
Capital expenditures	41,158	45,158
Segment Reconciling Items
Segment Reporting, Revenue Reconciling Item [Line Items]
Acquisition-related charges and intangible amortization	(20,313)	(22,188)
Exit and realignment charges, net	(27,356)	(15,674)
Share-based compensation	$ 690	$ 113